Omega Healthcare Investors, Inc.

Omega Healthcare Investors, Inc.'s next confirmed earnings release is scheduled for November 3, 2026.

As of June 30, 2026, Omega Healthcare Investors, Inc. has 299.11M shares outstanding.

As of June 30, 2026, Omega Healthcare Investors, Inc. maintains a current ratio of 5.93, meaning it holds 5.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 71.33, indicating elevated leverage, while an interest coverage ratio of 6.81 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Omega Healthcare Investors, Inc. posted a return on equity (ROE) of 16.54, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 10.71 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 8.35, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 10.33, useful for judging operating efficiency across full business cycles. The company generates approximately 15.52M in revenue per employee across its workforce of 66.75, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Omega Healthcare Investors, Inc. recorded 13.19M in income tax expense. That works out to an effective tax rate of 1.81, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 728.92M, leaving 693.46M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on August 28, 2026, Omega Healthcare Investors, Inc.'s stock has gained approximately 24.14% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Omega Healthcare Investors, Inc. generated 1.04B in revenue and converted that into 693.46M in net income, yielding earnings per share of 2.31. EBITDA reached 1.14B, while operating income came in at 652.82M.

As of June 30, 2026, Omega Healthcare Investors, Inc. holds 31.53M in cash and equivalents against 3.25B in total debt, resulting in a net debt position of 3.22B. Total book value stands at 4.35B, with working capital of 1.41B providing operational flexibility.

Omega Healthcare Investors, Inc. produced 719.42M in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Omega Healthcare Investors, Inc. posted a gross margin of 97.42, reflecting its pricing power and cost economics. The operating margin of 63.04 and net profit margin of 66.96 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Omega Healthcare Investors, Inc. paid dividends of 2.16 per share. The dividend payout ratio of 85.31 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.